Long-term Clinical and Radiographic Results of Revision Anterior Cruciate Ligament Reconstruction Using a Single-bundle Technique and External Tenodesis With Achilles Tendon Allograft.
Launched by ISTITUTO ORTOPEDICO RIZZOLI · Mar 5, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the long-term outcomes of a specific knee surgery called revision anterior cruciate ligament (ACL) reconstruction. This surgery is performed on patients who have previously had ACL surgery that did not fully heal or work as expected. In this trial, researchers are focusing on a technique that uses a single-bundle approach combined with an external support method, using a graft from a donor's Achilles tendon. The goal is to see how well this surgical method works over time and to understand the risks, such as the potential development of arthritis in the knee.
To participate in this study, patients need to be between 18 and 50 years old and have undergone the specific type of revision surgery at least two years ago. They also need to have provided consent to take part in the study and have a radiograph (an X-ray) of their knee taken around the time of their surgery. However, those with advanced knee arthritis, severe obesity, or other significant health issues will not be eligible. Participants can expect to contribute to valuable research that could help improve future ACL surgeries and outcomes for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age between 18 and 50 years at the time of surgery;
- • 2. Male and female gender;
- • 3. Patients who have undergone revision of anterior cruciate ligament reconstruction with a single-bundle "Over-The-Top" technique and external tenodesis using Achilles tendon allograft, with or without associated procedures, at least 2 years post-surgery;
- • 4. A radiograph taken immediately before or after the surgery of the affected knee;
- • 5. Patients who have provided consent to participate in the study.
- Exclusion Criteria:
- • 1. Patients no longer accessible;
- • 2. Patients who deny consent to participate in the study;
- • 3. Advanced knee osteoarthritis (Outerbridge grade III-IV) at the time of surgery;
- • 4. Severe obesity (BMI \> 35);
- • 5. Lower limb conditions that prevent the patient from maintaining an upright position with full weight-bearing during the assessment;
- • 6. Infection or hematological or rheumatic conditions at the time of the assessment.
About Istituto Ortopedico Rizzoli
Istituto Ortopedico Rizzoli is a renowned orthopedic research and treatment institute based in Bologna, Italy, dedicated to advancing musculoskeletal health through innovative clinical trials and cutting-edge medical practices. With a strong emphasis on research, the institute collaborates with leading experts in orthopedics, rehabilitation, and related fields to develop and evaluate new therapies and surgical techniques. Committed to improving patient outcomes, Istituto Ortopedico Rizzoli not only focuses on high-quality clinical care but also fosters a robust research environment that supports the translation of scientific findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported